Novartis Vaccines and Diagnostics

Italy

1 June 2020 - 31 May 2021

No articles found. Novartis Vaccines and Diagnostics did not contribute to any primary research papers from Nature Index journals in the current 12 month window.

GlaxoSmithKline plc. (GSK)

↳ Novartis Vaccines and Diagnostics

Cellzome GmbH

GSK Neural Pathways Discovery Performance Unit, Singapore

GSK Vaccines Institute for Global Health Srl

GlaxoSmithKline (GSK) Jurong

GlaxoSmithKline AG, Switzerland

GlaxoSmithKline Australia Pty. Ltd.

GlaxoSmithKline Belgium

GlaxoSmithKline France

GlaxoSmithKline Pharmaceuticals Limited

GlaxoSmithKline R&D Bangalore

GlaxoSmithKline R&D China

GlaxoSmithKline R&D Verona

GlaxoSmithKline Spain

GlaxoSmithKline USA

GlaxoSmithKline Vaccines (GSK Vaccines)

GlaxoSmithKline Vaccines Singapore

Glycovaxyn AG

Human Genome Sciences, Inc.

Novartis Vaccines and Diagnostics GmbH

Novartis Vaccines and Diagnostics, Inc.

Novartis Vaccines and Diagnostics, Inc. - Cambridge

Okairos AG

Okairos AG, Rome

Sirtris Pharmaceuticals, Inc.

TESARO, Inc.

Return to institution outputs

Latest supplement

Nature Index 2021 Science cities

Many leading science cities are active in research related to the UN Sustainable Development Goals. This Nature Index supplement showcases how they are supporting climate change and clean energy targets, protecting oceans, coastal communities and food security.

Access free